In a recent study published in the journal Eurosurveillance, researchers investigated the unusual rise in emergency department (ED) visits for pneumonia among children aged 5–14 years in England since November 2023.
Their findings indicate that this increase, which persisted into early summer 2024, was primarily driven by the bacteria Mycoplasma pneumoniae (MP), even as other seasonal respiratory infections decreased.
Background
Respiratory infections during the winter often burden healthcare services in the UK. The UK Health Security Agency (UKHSA) manages a surveillance program that tracks and reports respiratory illnesses yearly to help understand and manage their impact.
Recently, an unusual rise in pneumonia cases among children between the ages of 5 and 14 was detected through the program, leading to an investigation to understand what was causing this unexpected increase.
About the study
The UKHSA’s program monitors respiratory infections through various systems, including lab reports, general practice data, and real-time tracking of ED visits.
The surveillance program includes data from primary care physicians, laboratory reports, hospital admissions, ED attendance, and telehealth calls, monitoring a range of respiratory indicators from the milder common colds, which are self-limiting, to more severe illnesses like pneumonia.
This monitoring helps identify mild and severe respiratory illnesses and their effects on the healthcare system, particularly during the high-demand winter months.
Findings
Beginning in November 2023, the number of children between the ages of 5 and 14 visiting EDs for pneumonia began to rise above historical expectations, as observed through the UKHSA’s syndromic surveillance system.
This elevated activity continued through December 2023 and did not follow the typical seasonal decline in January 2024. Instead, the higher-than-expected number of pneumonia-related ED visits persisted between February and July 2024.
During this period, 2,532 pneumonia-related ED visits were recorded in this age group, which, while lower than the 45,003 cases reported in individuals aged 15 years and older, was still significantly higher than in previous years.
For context, the average number of visits during the same period of 2019-20 and 2022-23 for this age group were, respectively, 607 and 818, highlighting a notable surge in 2024.
Further analysis using data from the Emergency Care Dataset (ECDS) and linked laboratory reports confirmed that, between November 2022 and May 2024, there were 14,096 pneumonia-related ED attendances, with 2,334 of these linked to positive microbiology results.
Among the pathogens identified, Respiratory Syncytial Virus (RSV) accounted for 16.6% of cases, influenza A virus for 9.8%, and MP for 9.3%.
While RSV and influenza followed their usual seasonal patterns, MP showed a marked increase in early 2024, particularly among children aged 5–14, where it was found in 32.2% of pneumonia cases.
Additionally, increasing trends in MP infections were observed in children between the ages of 1 and 4, suggesting a broader impact across younger age groups.
Conclusions
The study found a persistent increase in emergency department visits for pneumonia among children between the ages of 5 and 14, primarily due to an unusual rise in MP infections during the winter of 2023-24, the first significant MP epidemic after the coronavirus disease 2019 (COVID-19) pandemic.
MP is a common cause of bacterial pneumonia among school-going children, and while infections are usually mild, some can lead to severe illness.
The study highlights the importance of real-time syndromic surveillance, which enabled early detection of this trend and timely public health responses. England’s 2023-24 MP epidemic was part of a global increase in MP cases, but the unusually prolonged season was notable.
The reasons for this prolonged activity remain unclear, but it might be linked to changes in disease transmission patterns due to pandemic-related public health measures.
In conclusion, the study underscores the value of the UK Health Security Agency’s (UKHSA) comprehensive respiratory surveillance program, which includes real-time syndromic surveillance to detect and quickly investigate unusual patterns of illness.
The findings also indicate the need for further research to better understand MP and its impact on public health.
- Persistent elevation in incidence of pneumonia in children in England, 2023/24. Todkill, D., Lamagni, T., Pebody, R., Ramsay, M., Woolham, D., Demirjian, A., Salzmann, A., Chand, M., Hughes, H.E., Bennett, C., Hope, R., Watson, C.H., Brown, C.S., Elliot, A.J. Eurosurveillance (2024). DOI: 10.2807/1560-7917.ES.2024.29.32.2400485, https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2024.29.32.2400485
News
Urban Microbes Are Eating Disinfectants – Are We Fueling a New Health Threat?
New research reveals that microbes in urban environments are evolving to withstand the very cleaning agents designed to eliminate them. The study also uncovers new strains in Hong Kong, previously only found in the [...]
Startling Study Shows High-Potency Cannabis Alters DNA
The study shows that frequent use of high-potency cannabis alters DNA, affecting genes related to energy and immune function. These changes differ between those with and without psychosis, suggesting cannabis use could influence mental health through biological [...]
New nanotherapy targets artery inflammation in cardiovascular disease
Inflammation of the arteries is a primary precursor and driver of cardiovascular disease—the No. 1 killer of people in the United States. This inflammation is associated with the buildup of dangerous plaque inside the [...]
Revolutionary Nanoparticle Therapy for Prostate Cancer
A groundbreaking research effort involving teams from the University of Virginia, Mount Sinai, the University of Michigan, the University of Texas, and others has displayed the clinical efficacy of an innovative therapy that utilizes nanoparticles and [...]
Antibody engineering drives innovation in drug development
Monoclonal antibodies (mAbs) are used to prevent, detect, and treat a broad spectrum of non-communicable and communicable diseases. Over the past few years, the market for mAbs has grown exponentially with an expected compound [...]
Breakthrough Study Reveals How Bladder Cancer Starts and Spreads
Researchers found that DNA mutations from antiviral enzymes and chemotherapy fuel early bladder cancer, while abnormal circular DNA in tumor cells drives resistance to therapy. These discoveries open new therapeutic avenues. A groundbreaking study led by [...]
AI and Quantum Mechanics Accelerate Drug Discovery
A recent article published in the Journal of Chemical Information and Modeling researchers at Southern Methodist University (SMU) have developed SmartCADD, an open-source virtual tool designed to speed [...]
Targeting ‘undruggable’ diseases: Researchers reveal new levels of detail in targeted protein degradation
Researchers at the University of Dundee have revealed in the greatest detail yet the workings of molecules called protein degraders which can be deployed to combat what have previously been regarded as "undruggable" diseases, [...]
Revolutionizing Virology: AI Discovers Over 160,000 New RNA Viruses
Largest discovery of new virus species sheds light on the hidden virosphere. Artificial intelligence (AI) has been used to reveal details of a diverse and fundamental branch of life living right under our feet and in every [...]
Cardiac Crisis: COVID-19 Doubles Risk of Heart Attacks, Strokes, and Death
Research indicates that COVID-19 survivors face doubled risks of severe cardiac events for years after recovery, especially if hospitalized. People with A, B, or AB blood types are particularly vulnerable, highlighting the need for personalized approaches [...]
AI steps into science limelight with Nobel wins
For long periods of its history, artificial intelligence has lurked in the hinterland of science, often unloved and unfunded—but two Nobel prizes in one week suggest its time in the sunshine has finally arrived. [...]
MIT Scientists Shed New Light on the Critical Brain Connections That Define Consciousness
A new study provides further evidence that consciousness depends on communication between the brain’s sensory and cognitive regions in the cortex. Our brains are constantly making predictions about our surroundings, enabling us to focus [...]
Common Chemicals Found in Shampoo and Plastic Could Be Quietly Disrupting Your Heart’s Rhythm
UC study of Fernald data links environmental phenols to heart toxicities Environmental phenols are present in numerous everyday consumer products, serving as preservatives in packaged foods, parabens in shampoos, and bisphenol A (BPA) in [...]
Revolutionary Brain Tech Offers New Hope for Stroke and Injury Recovery
University of Pittsburgh researchers report that deep brain stimulation (DBS) can effectively enhance motor functions in individuals with arm and hand paralysis due to brain injuries, with promising results from early human and monkey [...]
NIH Scientists Discover Gene Responsible for Rare Eye Disease
Findings supported by the NIH pave the way for the development of genetic testing, clinical trials, and therapies. Researchers at the National Institutes of Health (NIH) and their collaborators have discovered a gene linked to certain [...]
Alzheimer’s Breakthrough: Synthetic THC Pill Proves Effective in Clinical Trial
Patients tolerated synthetic THC (dronabinol) well, without the adverse effects commonly associated with existing Alzheimer’s agitation medications. A study conducted by researchers from Johns Hopkins University School of Medicine and Tufts University School of Medicine found that a pill form [...]